Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial. - Cleary JM; Springfeld C; Arnold D; Hollebecque A; Gbolahan O; Nagasaka M; Siena S; Opdam F; Sunakawa Y; Cassier PA; Trikha G; Gort EH; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026)